Company: NKLR
Filing Date: 2025-09-16
Form Type: 424B3
Source: 0001213900-25-087981
Chunk: 697

Company: Terra Innovatum Global N.V.
Filing Date: 2025-09-16
Form: 424B3
Chunk 697
---
 GICS category that operate in a similar industry and share comparable characteristics. Management also provided comparable companies that were reviewed as secondary comparison and found overlaps while conducting the fairness opinion assessment. We also used a Guideline Transaction Method to support the fairness opinion assessment. These were independently obtained and examined by us. Additional details of the analysis performed can be found in the associated proxy statement. In the course of our investigation, we have assumed and relied upon the accuracy and completeness of the financial statements, forecasts related to the unit level economics and regulatory approval plan, and other information provided to us by GSRT and the Company and we have further relied upon the assurances of management that they were unaware of any facts that would make the information provided to us incomplete or misleading in any material Annex E-2 respect for the purposes of this Opinion. We have not assumed any responsibility for independent verification of such information or assurances. With respect to the Terra Innovatum company outlook, we have been advised by Terra Innovatum, and have assumed, that they have been reasonably prepared on bases reflecting the good faith judgement of the management of Terra Innovatum as to the future financial performance of Terra Innovatum. Given GSRT’s nature as a special purpose acquisition company, for purposes of our opinion and with GSRT’s consent, we have assumed a value of $10.00 per share in calculating the value of the ordinary shares to be issued as the Transaction Consideration under the Business Combination Agreement, with such $10.00 value being based on GSRT’s initial public offering price, and GSRT’s approximate Trust Account cash per outstanding share of GSRT Class A Ordinary Shares (excluding, for the avoidance of doubt, the dilutive impact of the GSRT Class B Shares or any warrants issued by GSRT). In rendering our opinion, we do not express any view or opinion as to what the value of any ordinary shares will be when issued pursuant to the Transaction or the price or range of prices at which any shares of GSRT Class A Ordinary Shares or other securities and financial instruments of or relating to GSRT may trade or otherwise be transferable at any time before or after announcement or consummation of the Transaction. In arriving at our opinion, we have not performed any independent appraisal, or physical inspection, of the assets of the Company. Our analysis does not constitute an examination, review of, or compilation of prospective financial statements in accordance with standards established by the American Institute of Certified Public Accountants (“AICPA”). We do not express an opinion or any other form of assurance on the reason